In many aligner workflows, a doctor asks to hold the lower incisors, change the staging of a canine, or improve posterior contacts. The instruction passes from the aligner brand to an external planning team and returns days later. One change is missing. Another review begins. No line on the invoice says “software,” but the practice has already paid through staff time and a delayed start.
I have an obvious interest in this subject. At SoftSmile, we have been developing treatment planning software for many years, and it is used by more than 80 aligner companies and labs. This experience has shown me the first fundamental mistake of many new brands: they invest in production, materials, packaging, and sales, but fail to secure control over the system that generates the treatment plan
The industry too often confuses plastic with the product. Manufacturing can be contracted while serious planning software cannot be developed quickly. It requires expertise in 3D geometry and biomechanics, direct participation by orthodontists, and years of feedback from real cases. The plastic delivers the plan; it does not create it.
Relatively few aligner companies own and actively develop a complete planning stack. Others license a platform or combine general-purpose software with an external design service. Licensing can be a sound decision. An established independent platform may be stronger than a new brand’s immature proprietary product. But the brand places its clinical tools, feature roadmap, data portability, and pace of improvement in another company’s hands. If that provider falls behind, the aligner brand falls behind with it and may be left competing on price, turnaround time, and sales coverage.
Where the bill arrives
Let’s examine the first issue — clinical control. When a doctor cannot edit or direct a change precisely, the instruction passes through a technician or another service provider. The doctor approves the plan and remains responsible for it, while someone else controls the tools used to build it. Each handoff creates another opportunity for clinical intent to be softened or lost.
Another cost factor is time. One additional revision round means another review by the doctor, another follow-up by staff, and more days before the case can start. Across a practice’s caseload, that burden compounds. A lower laboratory fee can lose its advantage when the practice absorbs repeated setup work and delayed starts.
Finally, treatment efficiency. Refinements have many causes, including case complexity, biology, patient compliance, and movement-specific limitations. Software should not be blamed for all of them. Yet limited planning tools, rigid staging rules, or a misunderstood instruction can create an avoidable gap between clinical intent and the manufactured series. The bill then arrives as another scan, a new setup, additional trays, more chair time, and a longer treatment.
Can outsourcing and AI solve the problem?
A strong third-party planning team can improve setups and reduce the burden on a practice. This is useful when a brand lacks an internal clinical and technical team. It also places another party between the doctor and the plan. Outsourcing works when the provider is tightly integrated and the doctor still has a clear, fast way to direct the setup.
AI will expand the software choices available to the market. It already accelerates tasks such as segmentation, setup generation, and staging. Its value will grow with better data and clinical validation. A faster black box, however, does not give the clinician more control. AI earns its place when its decisions are visible, editable, and subject to the doctor’s judgment.
Three questions doctors should ask
· Can I directly edit the setup or specify changes without multiple intermediaries?
· Who controls the software roadmap, and how often is the platform improved and clinically validated?
· Can I export my case data and treatment files if the provider changes?
In conclusion, an aligner company does not always have to build its own software. However, it does need a credible software strategy and a partner whose incentives support long-term clinical improvement. An aligner company without serious software capability is renting its clinical core. Doctors will eventually feel the cost, even when it never appears on the invoice.